Study of LUCAR-20S in Patients With R/R NHL

NCT04176913 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Both the sponsors and collaborator are considering terminating the study

Conditions

Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Small Lymphocytic Lymphoma

Interventions

DRUG: LUCAR-20S CAR-T cells

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]